| Literature DB >> 34511869 |
Robert W Arnold1, Samuel J Martin2, Joshua R Beveridge3, Andrew W Arnold4, Stephanie L Arnold4, Nathanael R Beveridge5, Kyle A Smith1,6.
Abstract
BACKGROUND: Handheld devices can automatically give an estimate of refraction. The established method for refraction comparison using spherical equivalent (M) and J0, J45 vector transformations by Bland-Altman analysis is too complex for non-eye doctors involved with vision screening and remote vision clinics. Therefore, a simpler comparison technique was developed.Entities:
Keywords: autorefractors; remote dispensing; spectacles; validation
Year: 2021 PMID: 34511869 PMCID: PMC8415895 DOI: 10.2147/OPTH.S326680
Source DB: PubMed Journal: Clin Ophthalmol ISSN: 1177-5467
Figure 1Compared oval solid prior ABCD effort with this ABCD composite ellipsoid used to grade spectacle comparison. The horizontal dimension is composed of J0 on x-axis and J45 on y-axis, while spherical equivalent is on the z-axis with over plus extending up and age-based over-minus tolerance extending down depending on expected accommodation.
Figure 2Limits of spectacle refraction sphere and cylinder spectacle components that indicate the low or high level optical need relative to resolving blur.
Spectacle Comparison
| Exam vs | Ellipsoid | Sphere/M | Cyl | J0 | J45 | Aniso | ||
|---|---|---|---|---|---|---|---|---|
| PlusoptiX | ALL | ICC | 0.72 | 0.88 | 0.57 | |||
| BA mean difference | 0.39 | −0.07 | 0.00 | |||||
| BA SD difference | 1.15 | 0.33 | 0.21 | |||||
| ABCD composite | 1.68 | 0.74 | 0.86 | 0.75 | ||||
| Need 2 and 3 | ICC | 0.65 | 0.84 | 0.66 | ||||
| BA mean difference | 0.99 | 0.03 | 0.01 | |||||
| BA SD difference | 1.62 | 0.43 | 0.31 | |||||
| ABCD composite | 2.03 | 1.00 | 0.91 | 0.75 | ||||
| Retinomax | ALL | ICC | 0.57 | 0.90 | 0.59 | |||
| BA mean difference | 1.55 | 0.02 | 0.00 | |||||
| BA SD difference | 1.77 | 0.27 | 0.21 | |||||
| ABCD composite | 1.55 | 0.77 | 0.72 | 1.25 | ||||
| Need 2 and 3 | ICC | 0.66 | 0.91 | 0.69 | ||||
| BA mean difference | 1.54 | 0.00 | −0.01 | |||||
| BA SD difference | 1.85 | 0.28 | 0.22 | |||||
| ABCD composite | 1.55 | 0.75 | 0.8 | 1.50 | ||||
| 2WIN | ALL | ICC | 0.67 | 0.80 | 0.49 | |||
| BA mean difference | 0.78 | −0.14 | 0.05 | |||||
| BA SD difference | 1.30 | 0.39 | 0.26 | |||||
| ABCD composite | 1.72 | 0.56 | 1.00 | 0.50 | ||||
| Need 2 and 3 | ICC | 0.65 | 0.88 | 0.58 | ||||
| BA mean difference | 1.60 | −0.08 | 0.07 | |||||
| BA SD difference | 1.93 | 0.45 | 0.34 | |||||
| ABCD composite | 2.44 | 1.13 | 1.14 | 1.00 |
Notes: Degree of spherocylinder similarity between refined retinoscopy and three portable autorefractors, Plusoptix A12, Retinomax K Plus and Adaptica WIN. The ABCD composite is a method devised by the Alaska Blind Child Discovery that uses limits of spectacle blur to create an oval from J0 and J45 components into Cyl, an age-accommodation based sphere for over and under spherical equivalent, and finally a three-dimensional ellipsoid which combines Cyl and sphere.
Abbreviations: ALL, 202 children less than 20 years old; Need 2 and 3, the 113 eyes with higher level spectacle requirements; ICC, intraclass correlation; BA, Bland–Altman; SD, standard deviation; M, spherical equivalent; Aniso, anisometropia; J0 and J45, vector transformations for astigmatism.
Figure 3Bland–Altman and ABCD composite grade for three handheld autorefractors comparing spectacle components spherical equivalent, J0 and J45 cylinder vector transformations for all 202 pediatric patients with high and low spectacle needs.
Figure 4Bland–Altman and ABCD composite comparison for the three handheld remote autorefractors for the n=113 eyes from pediatric patients with higher level 2 and level 3 spectacle needs.
Figure 5A comparison of correlations comparing three ABCD composite components (spherical equivalent, composite J0×J45 cylinder and ellipsoid) for the Plusoptix, 2WIN and Retinomax handheld autorefractors.
Validation Statistic for Amblyopia Screening
| AAPOS Amblyopia Detection | Instrument Referral Criteria | Sensitivity | Specificity | PPV | A | B | C | D | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Plusoptix | 2013 | Sens | H2 C1.5 M3 A1.25 | 91% | 72% | 72% | 81 | 32 | 8 | 81 |
| Refer | H2.5 C2 M3.5 A1.5 | 80% | 83% | 79% | 71 | 19 | 18 | 94 | ||
| Spec | H3 C2.5 M4 A2 | 67% | 94% | 90% | 60 | 7 | 29 | 106 | ||
| 2021 | Sens | M2 H2.25 C1.75 A1.25 | 95% | 76% | 75% | 83 | 28 | 4 | 87 | |
| Refer | M2.5 H2.5 C2 A1.5 | 83% | 83% | 78% | 72 | 20 | 15 | 95 | ||
| Spec | M2.5 H3.5 C2.5 A1.75 | 64% | 94% | 89% | 56 | 7 | 31 | 108 | ||
| Retinomax | 2013 | Sens | H2.5 C1.25 M3 A1.1 | 96% | 58% | 64% | 85 | 48 | 4 | 65 |
| Refer | H3 C1.75 M3.25 A1.75 | 84% | 73% | 71% | 75 | 30 | 14 | 83 | ||
| Spec | H3.5 C2 M3.5 A2 | 78% | 94% | 91% | 69 | 7 | 20 | 106 | ||
| 2021 | Sens | H3 C1.5 M1.75 A1.25 | 93% | 48% | 57% | 81 | 60 | 6 | 55 | |
| Refer | H3.5 C1.75 M2 A1.5 | 90% | 58% | 62% | 78 | 48 | 9 | 67 | ||
| Spec | H4 C2 M2.5 A2 | 80% | 72% | 69% | 70 | 32 | 17 | 83 | ||
| 2WIN | 2013 | Sens | H1.5 C1.75 M3 A1.5 | 90% | 70% | 70% | 80 | 34 | 9 | 79 |
| Refer | H2.5 C2.25 M3.25 A1.75 | 72% | 88% | 82% | 64 | 14 | 25 | 99 | ||
| Spec | H3 C2.5 M3.5 A2 | 58% | 91% | 84% | 52 | 10 | 37 | 103 | ||
| 2021 | Sens | H1.75 C1.5 M1.75 A1.25 | 92% | 63% | 65% | 80 | 43 | 7 | 72 | |
| Refer | H2.25 C2 M2 A1.5 | 87% | 81% | 78% | 76 | 22 | 11 | 93 | ||
| Spec | H2.75 C2.25 M2.5 A1.75 | 75% | 88% | 82% | 65 | 14 | 22 | 101 | ||
Notes: Three non-cycloplegic portable autorefractors, the Plusoptix A12, The Retinomax, and the Adaptica 2WIN, are compared to AAPOS 2013 older triad guidelines6 and proposed 2021 guidelines. Instrument referral criteria for each device are customized to offer a more sensitive (Sens) option, a more specific option (SpeC), and a routine (Refer) option. The criteria are all those interpretations with hyperopia (H), cylinder (C), myopia (M) and anisometropia (A) greater than or equal to the adjacent number in diopters.
Abbreviations: PPV, positive predictive value; A, number referred with risk factor; B, number referred without risk factors; C, number not referred but with risk factors; D, number not referred without risk factors.
Figure 6Receiver operating characteristic (ROC) curve comparing portable autorefractors Plusoptix S12 (orange squares), Adaptica 2WIN (blue stars) and Retinomax (gray circles) for 202 pediatric patients with high 43% prevalence refractive amblyopia risk factors. The older triad of the 2013 AAPOS uniform guideline is shown in bold compared to the proposed 2021 AAPOS Uniform Guidelines for patients older than four years shown in delicate lines.